Literature DB >> 9350333

Effect of 4-methylumbelliferone on cell-free synthesis of hyaluronic acid.

T Nakamura1, M Funahashi, K Takagaki, H Munakata, K Tanaka, Y Saito, M Endo.   

Abstract

Human skin fibroblasts were cultured in the presence of 0.5 mM 4-methylumbelliferone for 12 h, and cell-free synthesis of hyaluronic acid was performed using membrane-rich fraction from the cells. The preincubation of the cells with 4-methylumbelliferone reduced hyaluronic acid synthesis to 15% of that of non-preincubated cells, although its chain length was not changed. On the other hand, without preincubation of the cells with 4-methylumbelliferone, hyaluronic acid synthesis was not changed even when 4-methylumbelliferone was added directly to the reaction mixture. These results suggest that 4-methylumbelliferone represses the expression of hyaluronic acid synthase on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350333     DOI: 10.1080/15216549700204041

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  17 in total

1.  Extracellular component hyaluronic acid and its receptor Hmmr are required for epicardial EMT during heart regeneration.

Authors:  Maria A Missinato; Kimimasa Tobita; Nicla Romano; James A Carroll; Michael Tsang
Journal:  Cardiovasc Res       Date:  2015-07-07       Impact factor: 10.787

2.  Size of the perivitelline space and incidence of polyspermy in rabbit and hamster oocytes.

Authors:  Nao Yoshida; Sueo Niimura
Journal:  Reprod Med Biol       Date:  2010-09-28

3.  Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation.

Authors:  Laura R Bohrer; Pavlina Chuntova; Lindsey K Bade; Thomas C Beadnell; Ronald P Leon; Nicholas J Brady; Yungil Ryu; Jodi E Goldberg; Stephen C Schmechel; Joseph S Koopmeiners; James B McCarthy; Kathryn L Schwertfeger
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

4.  Modulation of hyaluronan synthase activity in cellular membrane fractions.

Authors:  Davide Vigetti; Anna Genasetti; Evgenia Karousou; Manuela Viola; Moira Clerici; Barbara Bartolini; Paola Moretto; Giancarlo De Luca; Vincent C Hascall; Alberto Passi
Journal:  J Biol Chem       Date:  2009-09-08       Impact factor: 5.157

5.  Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS.

Authors:  Andre Michael Mueller; Bo Hyung Yoon; Saud Ahmed Sadiq
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

6.  Androgen-stimulated UDP-glucose dehydrogenase expression limits prostate androgen availability without impacting hyaluronan levels.

Authors:  Qin Wei; Robert Galbenus; Ashraf Raza; Ronald L Cerny; Melanie A Simpson
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

7.  Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer.

Authors:  Travis J Yates; Luis E Lopez; Soum D Lokeshwar; Nicolas Ortiz; Georgios Kallifatidis; Andre Jordan; Kelly Hoye; Norman Altman; Vinata B Lokeshwar
Journal:  J Natl Cancer Inst       Date:  2015-04-13       Impact factor: 13.506

8.  Inhibition of hyaluronan secretion by novel coumarin compounds and chitin synthesis inhibitors.

Authors:  Alexandra A Tsitrina; Igor V Krasylov; Dmitry I Maltsev; Irina N Andreichenko; Viktoria S Moskvina; Dmitry N Ivankov; Elena V Bulgakova; Mikhail Nesterchuk; Vera Shashkovskaya; Nataliya O Dashenkova; Vladimir P Khilya; Arsen Mikaelyan; Yuri Kotelevtsev
Journal:  Glycobiology       Date:  2021-09-09       Impact factor: 4.313

Review 9.  Targeting hyaluronic acid family for cancer chemoprevention and therapy.

Authors:  Vinata B Lokeshwar; Summan Mirza; Andre Jordan
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

10.  The hyaluronan synthesis inhibitor 4-methylumbelliferone exhibits antitumor effects against mesenchymal-like canine mammary tumor cells.

Authors:  Teruyoshi Saito; Tamura Dai; Ryuji Asano
Journal:  Oncol Lett       Date:  2013-01-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.